Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Lnc-PSMA8-1 activated by GEFT promotes rhabdomyosarcoma progression via upregulation of mTOR expression by sponging miR-144-3p

Fig. 7

lnc-PSMA8-1 suppresses miR-144-3p function. A: Proliferative capability of RD and RH30 cells transfected with lnc-PSMA8-1 siRNA in combination with miR-144-3p inhibitor as determined through CCK-8 cell proliferation assay. B: Apoptosis rates of RD and RH30 cells transfected with lnc-PSMA8-1 siRNA in combination with miR-144-3p inhibitor as determined through flow cytometry assay. C-D: Invasion (C) and migratory (D) of RD and RH30 cells transfected with lnc-PSMA8-1 siRNA in combination with miR-144-3p inhibitor as determined through transwell system

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us